These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Prevalence, expenditures, utilization, and payment for persons with MS in insured populations. Pope GC; Urato CJ; Kulas ED; Kronick R; Gilmer T Neurology; 2002 Jan; 58(1):37-43. PubMed ID: 11781403 [TBL] [Abstract][Full Text] [Related]
46. High opioid doses, naloxone, and central nervous system active medications received by Medicare-enrolled adults. Silva Almodóvar A; Nahata MC J Am Geriatr Soc; 2023 Jan; 71(1):98-108. PubMed ID: 36289563 [TBL] [Abstract][Full Text] [Related]
47. Association Between Dual Trajectories of Opioid and Gabapentinoid Use and Healthcare Expenditures Among US Medicare Beneficiaries. Zhou L; Bhattacharjee S; Kwoh CK; Malone DC; Tighe PJ; Reisfield GM; Slack M; Wilson DL; Lo-Ciganic WH Value Health; 2021 Feb; 24(2):196-205. PubMed ID: 33518026 [TBL] [Abstract][Full Text] [Related]
48. The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations. Dufour R; Joshi AV; Pasquale MK; Schaaf D; Mardekian J; Andrews GA; Patel NC Pain Pract; 2014 Mar; 14(3):E106-15. PubMed ID: 24289539 [TBL] [Abstract][Full Text] [Related]
49. Opioid Use Among Individuals With Spinal Cord Injury: Prevalence Estimates Based on State Prescription Drug Monitoring Program Data. DiPiro ND; Murday D; Corley EH; DiPiro TV; Krause JS Arch Phys Med Rehabil; 2021 May; 102(5):828-834. PubMed ID: 33227268 [TBL] [Abstract][Full Text] [Related]
50. Generic and Brand-Name Thyroid Hormone Drug Use Among Commercially Insured and Medicare Beneficiaries, 2007 Through 2016. Ross JS; Rohde S; Sangaralingham L; Brito JP; Choi L; Dutcher SK; Graham DJ; Jenkins MR; Lipska KJ; Mendoza M; Qiang Y; Wang Z; Wu Y; Yao X; Shah ND J Clin Endocrinol Metab; 2019 Jun; 104(6):2305-2314. PubMed ID: 30690529 [TBL] [Abstract][Full Text] [Related]
51. Beneficiary characteristics and vaccinations in the end-stage renal disease Medicare beneficiary population, an analysis of claims data 2006-2015. Shen AK; Kelman JA; Warnock R; Zhang W; Brereton S; McKean S; Wernecke M; Chu S; Gellin BG Vaccine; 2017 Dec; 35(52):7302-7308. PubMed ID: 29132990 [TBL] [Abstract][Full Text] [Related]
52. Use of Chronic Care Management Codes for Medicare Beneficiaries: a Missed Opportunity? Gardner RL; Youssef R; Morphis B; DaCunha A; Pelland K; Cooper E J Gen Intern Med; 2018 Nov; 33(11):1892-1898. PubMed ID: 30030734 [TBL] [Abstract][Full Text] [Related]
53. Opioid Prescribing Patterns and Complications in the Dermatology Medicare Population. Cao S; Karmouta R; Li DG; Din RS; Mostaghimi A JAMA Dermatol; 2018 Mar; 154(3):317-322. PubMed ID: 29417134 [TBL] [Abstract][Full Text] [Related]
54. Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011-2017. Zhang H; Paice J; Portenoy R; Bruera E; Reid MC; Bao Y Oncologist; 2021 Oct; 26(10):e1890-e1892. PubMed ID: 34227175 [TBL] [Abstract][Full Text] [Related]
55. Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States. Krishnarajah G; Demissie K; Lefebvre P; Gaur S; Sheng Duh M Hum Vaccin Immunother; 2014; 10(8):2255-66. PubMed ID: 25424930 [TBL] [Abstract][Full Text] [Related]
56. Association Between Opioid Tapering and Subsequent Health Care Use, Medication Adherence, and Chronic Condition Control. Magnan EM; Tancredi DJ; Xing G; Agnoli A; Jerant A; Fenton JJ JAMA Netw Open; 2023 Feb; 6(2):e2255101. PubMed ID: 36749586 [TBL] [Abstract][Full Text] [Related]
57. Opioid prescription and diabetes among Medicare beneficiaries. Casagrande SS; Beccera AZ; Rust KF; Cowie CC Diabetes Res Clin Pract; 2023 Feb; 196():110240. PubMed ID: 36610545 [TBL] [Abstract][Full Text] [Related]
58. Robust Prescription Monitoring Programs and Abrupt Discontinuation of Long-term Opioid Use. Bao Y; Zhang H; Wen K; Johnson P; Jeng PJ; Witkin LR; Nicholson S; Reid MC; Schackman BR Am J Prev Med; 2021 Oct; 61(4):537-544. PubMed ID: 34233856 [TBL] [Abstract][Full Text] [Related]
59. Prevalence and trends in obesity among aged and disabled U.S. Medicare beneficiaries, 1997-2002. Doshi JA; Polsky D; Chang VW Health Aff (Millwood); 2007; 26(4):1111-7. PubMed ID: 17630454 [TBL] [Abstract][Full Text] [Related]
60. Patterns of opioid and benzodiazepine use with gabapentin among disabled Medicare beneficiaries - A retrospective cohort study. Olopoenia A; Camelo-Castillo W; Qato DM; Adekoya A; Palumbo F; Sera L; Simoni-Wastila L Drug Alcohol Depend; 2022 Jan; 230():109180. PubMed ID: 34847506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]